Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2011

Mar 18, 2011

29875_dirs_2011-03-18_adec63b4-e1df-45e0-883a-69502a7be374.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2011-03-09

Reporting Person: Joyner J. David (EVP, Sales & Account Services)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12094 Direct
Common Stock (restricted) 4141 Direct
Common Stock (restricted) 6451 Direct
Common Stock (restricted) 2973 Direct
Common Stock (restricted) 6680 Direct
Common Stock (restricted) 17794 Direct
Common Stock (restricted) 1326 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $34.42 2014-04-02 Common Stock (125250) Direct
Stock Option $41.17 2015-04-01 Common Stock (95135) Direct
Stock Option $28.10 2016-04-01 Common Stock (77619) Direct
Stock Option $36.23 2017-04-01 Common Stock (45897) Direct
Stock Option $20.23 2015-03-01 Common Stock (93903) Direct

Footnotes

F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2014.

F2: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2013.

F3: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 2/17/2012 and 2/17/2013.

F4: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2012.

F5: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2014.

F6: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 2/18/2012.

F7: Option became exercisable in three equal annual installments on 4/2/2008.

F8: Option became exercisable in three equal annual installments on 4/1/2009.

F9: Option became exercisable in three equal annual installments on 4/1/2010.

F10: Option becomes exercisable in three equal annual installments, commencing 4/1/2011.

F11: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.